West Nile Virus Infections Global Clinical Trials Review, H2, 2014

Date: November 28, 2014
Pages: 57
Price:
US$ 2,500.00 US$ 2,000.00
Offer valid until December 31, 2016!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: W57E226FD7AEN
Leaflet:

Download PDF Leaflet

West Nile Virus Infections Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “West Nile Virus Infections Global Clinical Trials Review, H2, 2014' provides data on the West Nile Virus Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on West Nile Virus Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating West Nile Virus Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
West Nile Virus Infections
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by G7 Countries: Proportion of West Nile Virus Infections to Infectious Disease Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of West Nile Virus Infections
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in West Nile Virus Infections Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
MacroGenics, Inc.
Clinical Trial Overview of MacroGenics, Inc.
Sarepta Therapeutics, Inc.
Clinical Trial Overview of Sarepta Therapeutics, Inc.
Sanofi
Clinical Trial Overview of Sanofi
Acuvax Ltd
Clinical Trial Overview of Acuvax Ltd
Clinical Trial Overview of Top Institutes / Government
The National Institute of Allergy and Infectious Diseases
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
National Institutes of Health Clinical Center
Clinical Trial Overview of National Institutes of Health Clinical Center
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES
West Nile Virus Infections Therapeutics, Global, Clinical Trials by Region, 2014
West Nile Virus Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
West Nile Virus Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
West Nile Virus Infections Therapeutics Clinical Trials, North America, Top Countries, 2014
Proportion of West Nile Virus Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014
West Nile Virus Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
West Nile Virus Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
West Nile Virus Infections Therapeutics, Global, Clinical Trials by Phase, 2014
West Nile Virus Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014
West Nile Virus Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014
West Nile Virus Infections Therapeutics, Global, Terminated Clinical Trials, 2014
West Nile Virus Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
West Nile Virus Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014
West Nile Virus Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014
West Nile Virus Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
West Nile Virus Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
West Nile Virus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by MacroGenics, Inc., 2014
West Nile Virus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarepta Therapeutics, Inc., 2014
West Nile Virus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014
West Nile Virus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Acuvax Ltd, 2014
West Nile Virus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014
West Nile Virus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2014

LIST OF FIGURES
West Nile Virus Infections Therapeutics, Global, Clinical Trials by Region (%), 2014
West Nile Virus Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
West Nile Virus Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2014
Proportion of West Nile Virus Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014
West Nile Virus Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
West Nile Virus Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
West Nile Virus Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014
West Nile Virus Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014
West Nile Virus Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014
West Nile Virus Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
West Nile Virus Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014
West Nile Virus Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014
West Nile Virus Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
GlobalData Methodology
Skip to top


Ask Your Question

West Nile Virus Infections Global Clinical Trials Review, H2, 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: